ARCA Biopharma Completes U.S. FDA Pre-IND Consultation for Potential COVID-19 Treatment

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • 08/17/2020 at 4:22 pm #10408
    Colorado BioScience AssocationColorado BioScience Association
    Keymaster
    Under the Coronavirus Treatment Acceleration Program (CTAP), the U.S. FDA provided feedback for ARCA’s clinical development plans for evaluating AB201 as a potential treatment for patients with severe cases of COVID-19.
  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.